OrbiMed’s DIH Holdings US DHAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-76,600
Closed -$358K 132
2025
Q3
$358K Hold
76,600
0.01% 108
2025
Q2
$469K Hold
76,600
0.01% 97
2025
Q1
$443K Buy
+76,600
New +$1.42M 0.01% 108

OrbiMed's DHAI Position: Q4 2025 in Review

OrbiMed sold out of DIH Holdings US (DHAI) in Q4 2025, closing a stake of 76,600 shares — an estimated $358K sold.

OrbiMed first reported a position in DHAI in Q1 2025 and held it in 3 quarters. The position peaked at $469K in Q2 2025. 0 funds tracked by Wall St. Rank hold DHAI as of Q4 2025.

  • OrbiMed reported no remaining DIH Holdings US position as of Q4 2025 after selling out during the quarter.
  • OrbiMed sold 76,600 DIH Holdings US shares in Q4 2025, an estimated $358K.
  • OrbiMed first reported a position in DIH Holdings US in Q1 2025 and held it in 3 quarters.
  • OrbiMed's DIH Holdings US position peaked at $469K in Q2 2025.
  • 0 funds tracked by Wall St. Rank held DIH Holdings US as of Q4 2025.

Based on OrbiMed's 13F filing for Q4 2025, filed 17 Feb 2026.